<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02370771</url>
  </required_header>
  <id_info>
    <org_study_id>2014/059/HP</org_study_id>
    <nct_id>NCT02370771</nct_id>
  </id_info>
  <brief_title>Proteomic Analysis in Sera From Patients With Erosive Hand Osteoarthritis</brief_title>
  <acronym>PASEO</acronym>
  <official_title>Proteomic Analysis in Sera From Patients With Erosive Hand Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hand osteoarthritis is a common phenotype of osteoarthritis which affects about 70 % of the&#xD;
      elderly population. Usually considered as a minor illness, it nevertheless leads to an&#xD;
      important functional impairment. The mechanism of this disease is still poorly known.&#xD;
      Furthermore there are 2 different subtypes : erosive and non erosive hand osteoarthritis from&#xD;
      which mechanisms may differ.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      This is a cross-sectional study recruiting patients with hand osteoarthritis addressed in&#xD;
      consultation of rheumatology and plastic surgery in Rouen University Hospital.&#xD;
&#xD;
      Two groups of patients will be studied: 20 patients with non erosive subtype of hand&#xD;
      osteoarthritis and 20 patients with erosive subtype of hand osteoarthritis.&#xD;
&#xD;
      A clinical evaluation of hand osteoarthritis will be performed. Blood sample for proteomic&#xD;
      analysis will be taken. Hand MRI and Bone Mineral Analyser will be performed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 9, 2015</start_date>
  <completion_date type="Actual">November 17, 2019</completion_date>
  <primary_completion_date type="Actual">November 17, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantification by label-free proteomic analysis of the serum of patients affected by hand osteoarthritis</measure>
    <time_frame>day 1</time_frame>
    <description>Assessments done using biological sampling</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Erosion in patients affected by hand osteoarthritis</measure>
    <time_frame>Day 1</time_frame>
    <description>Number of Erosion in patients affected by hand osteoarthritis is evaluated using Bone Mineral Analyser</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Erosive Hand Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Patient with hand osteoarthritis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biological sampling and Radiographic evaluation of patient with erosive and non erosive hand osteoarthritis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biological sampling</intervention_name>
    <description>Biological sampling to identify by label-free proteomic analysis of a combination of serum biomarkers in patients with Erosive and non erosive hand Osteoarthritis</description>
    <arm_group_label>Patient with hand osteoarthritis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Radiographic evaluation</intervention_name>
    <description>Radiographic assessments using Bone Mineral Analyser and Hand MRI will be done in patients with Erosive and non erosive hand Osteoarthritis</description>
    <arm_group_label>Patient with hand osteoarthritis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female gender&#xD;
&#xD;
          -  Less than 70 years old&#xD;
&#xD;
          -  Diagnosis of hand osteoarthritis according to ACR criteria ACR after exclusion of&#xD;
             thumb base osteoarthritis:&#xD;
&#xD;
               1. Hand pain, aching or stiffness most of the days during the preceding month&#xD;
&#xD;
               2. Hard tissue enlargement of at least two of 8 selected joints *&#xD;
&#xD;
               3. Hard tissue enlargement of at least two distal interphalangeal joint&#xD;
&#xD;
               4. Swelling of fewer than three metacarpophalangeal joint&#xD;
&#xD;
               5. Deformity of at least one of 10 selected joints * Patients have to fulfil&#xD;
                  criteria 1, 2 AND 3 + 4 OR 5 * the 8 selected joints are the second and third&#xD;
                  distal interphalangeal joint and the second and third proximal interphalangeal of&#xD;
                  both hands Then confirm by experts' committee&#xD;
&#xD;
          -  Exclusively symptomatic treatment&#xD;
&#xD;
          -  For women of child-bearing age, use of an effective contraceptive method&#xD;
&#xD;
          -  French spoken and read&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Male gender&#xD;
&#xD;
          -  More than 70 years old&#xD;
&#xD;
          -  Hemochromatosis&#xD;
&#xD;
          -  Inflammatory arthritis&#xD;
&#xD;
          -  Cristal induced arthritis&#xD;
&#xD;
          -  Active diseases such as infection or cancer&#xD;
&#xD;
          -  Use of DMARDs&#xD;
&#xD;
          -  Pregnant or breast-feeding woman&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gilles AVENEL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UH Rouen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>February 18, 2015</study_first_submitted>
  <study_first_submitted_qc>February 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2015</study_first_posted>
  <last_update_submitted>June 26, 2020</last_update_submitted>
  <last_update_submitted_qc>June 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

